ALKERMES | ALKS - Attività Correnti

Prezzo Delle Azioni
33.59
Cambio Giornaliero
-0.13 -0.37%
Mensile
-3.60%
Annuale
5.68%
Q2 Previsione
32.32




Attività Correnti Cambiamento Data
AbbVie USD 29.06B 523M 2025-12
Acadia Pharmaceuticals USD 1.06B 14.31M 2025-12
ALKERMES USD 1.93B 187.5M 2025-12
Amgen USD 31.48B 2.42B 2026-03
Biogen USD 9.19B 216.3M 2026-03
BioMarin Pharmaceutical USD 3.95B 98.95M 2025-12
Bristol-Myers Squibb USD 27.21B 2.18B 2026-03
Coherus Biosciences USD 206.71M 254.25M 2025-12
Eli Lilly USD 54.84B 794M 2026-03
Gilead Sciences USD 19.89B 1.05B 2025-12
Heron Therapeutics USD 238.07M 8.67M 2025-12
Ionis Pharmaceuticals USD 2.94B 52M 2026-03
J&J USD 59.17B 3.55B 2026-03
Malin Corporation EUR 62.6M 26.7M 2024-12
Merck USD 43.52B 4.04B 2025-12
Minerva Neurosciences USD 83.1M 70.08M 2025-12
Nektar Therapeutics USD 266.27M 15.09M 2025-12
Neurocrine Biosciences USD 2.52B 364.3M 2025-12
Otsuka Holdings JPY 1.6T 21.76B 2026-03
Ovoca Bio EUR 1.56M 3.39M 2025-06
Pfizer USD 46.92B 3.22B 2025-09
Regeneron Pharmaceuticals USD 18.21B 187.3M 2026-03
Vertex Pharmaceuticals USD 11.2B 631.4M 2025-12